Literature DB >> 7581449

Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex.

C G Bönnemann1, R Modi, S Noguchi, Y Mizuno, M Yoshida, E Gussoni, E M McNally, D J Duggan, C Angelini, E P Hoffman.   

Abstract

The dystrophin associated proteins (DAPs) are good candidates for harboring primary mutations in the genetically heterogeneous autosomal recessive muscular dystrophies (ARMD). The transmembrane components of the DAPs can be separated into the dystroglycan and the sarcoglycan complexes. Here we report the isolation of cDNAs encoding the 43 kD sarcoglycan protein beta-sarcoglycan (A3b) and the localization of the human gene to chromosome 4q12. We describe a young girl with ARMD with truncating mutations on both alleles. Immunostaining of her muscle biopsy shows specific loss of the components of the sarcoglycan complex (beta-sarcoglycan, alpha-sarcoglycan (adhalin), and 35 kD sarcoglycan). Thus secondary destabilization of the sarcoglycan complex may be an important pathophysiological event in ARMD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581449     DOI: 10.1038/ng1195-266

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  105 in total

1.  Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin.

Authors:  Y Mizuno; T G Thompson; J R Guyon; H G Lidov; M Brosius; M Imamura; E Ozawa; S C Watkins; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface.

Authors:  J J O'Toole; K A Deyst; M A Bowe; M A Nastuk; B A McKechnie; J R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  2004 William Allan Award address. Cloning of the DMD gene.

Authors:  Louis M Kunkel
Journal:  Am J Hum Genet       Date:  2005-02       Impact factor: 11.025

5.  Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein.

Authors:  M Nissinen; A Helbling-Leclerc; X Zhang; T Evangelista; H Topaloglu; C Cruaud; J Weissenbach; M Fardeau; F M Tomé; K Schwartz; K Tryggvason; P Guicheney
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

6.  Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F.

Authors:  Derek J Milner; Stephen J Kaufman
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.

Authors:  E M McNally; M R Passos-Bueno; C G Bönnemann; M Vainzof; E de Sá Moreira; H G Lidov; K B Othmane; P H Denton; J M Vance; M Zatz; L M Kunkel
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 8.  [Molecular pathogenesis of muscular diseases].

Authors:  K Ohlendieck
Journal:  Naturwissenschaften       Date:  1996-12

9.  Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7.

Authors:  M C Speer; J M Vance; J M Grubber; F Lennon Graham; J M Stajich; K D Viles; A Rogala; R McMichael; J Chutkow; C Goldsmith; R W Tim; M A Pericak-Vance
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Dusp6 is a genetic modifier of growth through enhanced ERK activity.

Authors:  Andy H Vo; Kayleigh A Swaggart; Anna Woo; Quan Q Gao; Alexis R Demonbreun; Katherine S Fallon; Mattia Quattrocelli; Michele Hadhazy; Patrick G T Page; Zugen Chen; Ascia Eskin; Kevin Squire; Stanley F Nelson; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.